News Conference News ESC 2019 New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises Michael O'Riordan September 04, 2019
News Conference News ESC 2019 BMI Not the Best Option for Predicting CV Events, Global Analysis Suggests Yael L. Maxwell September 02, 2019
News Conference News ESC 2019 Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4 Michael O'Riordan September 02, 2019
News Conference News ESC 2018 Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE Michael O'Riordan August 28, 2018
News Conference News ESC 2018 ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients Todd Neale August 26, 2018
News Conference News ESC 2018 Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE Shelley Wood August 26, 2018
News Conference News ESC 2018 MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis Todd Neale August 26, 2018
News Conference News ESC 2018 Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61 Michael O'Riordan August 26, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Conference News ESC 2017 VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost? Shelley Wood August 28, 2017
News Conference News ESC 2016 New Cardio-Oncology Position Statement Reviews Cardiovascular Side Effects of Cancer Therapies and Calls for Further Study Shelley Wood August 27, 2016
News Conference News ESC 2015 ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff September 09, 2015
News Conference News ESC 2015 EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS Caitlin E. Cox September 02, 2015
News Conference News ESC 2015 DAPT Analysis Eases Concerns Over Slightly Higher Death Rate Seen With Extended Thienopyridine Use Caitlin E. Cox September 01, 2015
News Conference News ASCOT: Unexplained Long-Term Mortality Benefit Found with Atorvastatin August 29, 2011